nach oben

International Orthopaedics

Erschienen in:

19.10.2020 | Invited Papers

Biological strategies for osteoarthritis: from early diagnosis to treatment

verfasst von: Alexander E. Weber, Ioanna K. Bolia, Nicholas A. Trasolini

Erschienen in: International Orthopaedics | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To provide an updated review of the literature on the use of orthobiologics as a potential treatment option to alleviate symptoms associated with osteoarthritis (OA), slow the progression of the disease, and aid in cartilage regeneration.

Methods

A comprehensive review of the literature was performed to identify basic science and clinical studies examining the role of orthobiologics in the diagnosis and management of osteoarthritis.

Results

Certain molecules (such as interleukin-6 (IL-6), interleukin-8 (IL-8), matrix metalloproteinase (MMPs), cartilage oligomeric matrix protein (COMP), and tumor necrosis factor (TNF), microRNAs, growth differentiation factor 11 (GDF-11)) have been recognized as biomarkers that are implicated in the pathogenesis and progression of degenerative joint disease (DJD). These biomarkers have been used to develop newer diagnostic applications and targeted biologic therapies for DJD. Local injection therapy with biologic agents such as platelet-rich plasma or stem cell–based preparations has been associated with significant improvement in joint pain and function in patients with OA and has increased in popularity during the last decade. The combination of PRP with kartogenin or TGF-b3 may also enhance its biologic effect. The mesenchymal stem cell secretome has been recognized as a potential target for the development of OA therapies due to its role in mediating the chondroprotective effects of these cells. Recent experiments have also suggested the modification of gut microbiome as a newer method to prevent OA or alter the progression of the disease.

Conclusions

The application of orthobiologics for the diagnosis and treatment of DJD is a rapidly evolving field that will continue to expand. The identification of OA-specific and joint-specific biomarker molecules for early diagnosis of OA would be extremely useful for the development of preventive and therapeutic protocols. Local injection therapies with HA, PRP, BMAC, and other stem cell–based preparations are currently being used to improve pain and function in patients with early OA or those with progressed disease who are not surgical candidates. Although the clinical outcomes of these therapies seem to be promising in clinical studies, future research will determine the true role of orthobiologic applications in the field of DJS.

Toumi H, Mazor M (2019) Osteoarthritis biomarkers and treatments

Tiderius CJ, Olsson LE, Leander P, Ekberg O, Dahlberg L (2003) Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med 49:488–492CrossRefPubMed

Tiderius CJ, Svensson J, Leander P, Ola T, Dahlberg L (2004) dGEMRIC (delayed gadolinium-enhanced MRI of cartilage) indicates adaptive capacity of human knee cartilage. Magn Reson Med 51:286–290CrossRefPubMed

Woodell-May JE, Sommerfeld SD (2020) Role of inflammation and the immune system in the progression of osteoarthritis. J Orthop Res 38:253–257. https://doi.org/10.1002/jor.24457CrossRefPubMed

Huebner K, Frank RM, Getgood A (2019) Ortho-biologics for osteoarthritis. Clin Sports Med 38:123–141. https://doi.org/10.1016/j.csm.2018.09.002CrossRefPubMed

Katz JN, Neogi T, Callahan LF, Block JA, Conaghan PG, Simon LS, Kraus VB, Hochberg MC (2020) Disease modification in osteoarthritis; pathways to drug approval. Osteoarthr Cartil Open 100059

Cotter EJ, Frank RM, Mandelbaum B (2020) Management of osteoarthritis-biological approaches: current concepts. J ISAKOS 5:27–31CrossRef

van Spil WE, Szilagyi IA (2020) Osteoarthritis year in review 2019: biomarkers (biochemical markers). Osteoarthr Cartil 28:296–315. https://doi.org/10.1016/j.joca.2019.11.007CrossRef

Kraus VB, Hsueh M-F (2019) Biomarkers and osteoarthritis. In: Genomic and Precision Medicine. Elsevier. pp. 429–444

10.

Chu CR, Rodeo S, Bhutani N, Goodrich LR, Huard J, Irrgang J, LaPrade RF, Lattermann C, Lu Y, Mandelbaum B, Mao J, McIntyre L, Mishra A, Muschler GF, Piuzzi NS, Potter H, Spindler K, Tokish JM, Tuan R, Zaslav K, Maloney W (2019) Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS/NIH U-13 Conference. JAAOS - J Am Acad Orthop Surg 27:e50–e63. https://doi.org/10.5435/jaaos-d-18-00305CrossRefPubMed

11.

Watt FE (2018) Osteoarthritis biomarkers: year in review. Osteoarthr Cartil 26:312–318. https://doi.org/10.1016/j.joca.2017.10.016CrossRef

12.

He Y, Manon-Jensen T, Arendt-Nielsen L, Petersen KK, Christiansen T, Samuels J, Abramson S, Karsdal MA, Attur M, Bay-Jensen AC (2019) Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis. Osteoarthr Cartil 27:611–620CrossRef

13.

Luo Y, He Y, Reker D, Gudmann NS, Henriksen K, Simonsen O, Ladel C, Michaelis M, Mobasheri A, Karsdal M (2018) A novel high sensitivity type II collagen blood-based biomarker, PRO-C2, for assessment of cartilage formation. Int J Mol Sci 19:3485CrossRefPubMedCentral

14.

Maly K, Schaible I, Riegger J, Brenner RE, Meurer A, Zaucke F (2019) The expression of thrombospondin-4 correlates with disease severity in osteoarthritic knee cartilage. Int J Mol Sci 20:447CrossRefPubMedCentral

15.

Ntoumou E, Tzetis M, Braoudaki M, Lambrou G, Poulou M, Malizos K, Stefanou N, Anastasopoulou L, Tsezou A (2017) Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes. Clin Epigenetics 9:127. https://doi.org/10.1186/s13148-017-0428-1CrossRefPubMedPubMedCentral

16.

Ragni E, De Luca P, Marmotti A, de Girolamo L (2019) miR-26a-5p is a stable reference gene for miRNA studies in chondrocytes from developing human cartilage. Cells 8:631CrossRefPubMedCentral

17.

Weber AE, Mlynarek RA, Cole BJ, Bedi A (2016) Overview on small molecule biologic and gene-based treatments in sports medicine. Oper Tech Orthop 26:62–67CrossRef

18.

Johnson K, Zhu S, Tremblay MS, Payette JN, Wang J, Bouchez LC, Meeusen S, Althage A, Cho CY, Wu X (2012) A stem cell–based approach to cartilage repair. Science 336:717–721CrossRefPubMed

19.

Jeon OH, Elisseeff J (2016) Orthopedic tissue regeneration: cells, scaffolds, and small molecules. Drug Deliv Transl Res 6:105–120. https://doi.org/10.1007/s13346-015-0266-7CrossRefPubMed

20.

Khan NM, Haseeb A, Ansari MY, Devarapalli P, Haynie S, Haqqi TM (2017) Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human osteoarthritis chondrocytes. Free Radic Biol Med 106:288–301. https://doi.org/10.1016/j.freeradbiomed.2017.02.041CrossRefPubMedPubMedCentral

21.

Park JS, Lee HJ, Lee DY, Jo HS, Jeong JH, Kim DH, Nam DC, Lee CJ, Hwang S-C (2015) Chondroprotective effects of wogonin in experimental models of osteoarthritis in vitro and in vivo. Biomol Ther 23:442CrossRef

22.

Chen Y, Huang J, Tang C, Chen X, Yin Z, Heng BC, Chen W, Shen W (2017) Small molecule therapeutics for inflammation-associated chronic musculoskeletal degenerative diseases: past, present and future. Exp Cell Res 359:1–9. https://doi.org/10.1016/j.yexcr.2017.07.027CrossRefPubMed

23.

Shi Y, Hu X, Cheng J, Zhang X, Zhao F, Shi W, Ren B, Yu H, Yang P, Li Z, Liu Q, Liu Z, Duan X, Fu X, Zhang J, Wang J, Ao Y (2019) A small molecule promotes cartilage extracellular matrix generation and inhibits osteoarthritis development. Nat Commun 10:1914. https://doi.org/10.1038/s41467-019-09839-xCrossRefPubMedPubMedCentral

24.

Deshmukh V, Hu H, Barroga C, Bossard C, Kc S, Dellamary L, Stewart J, Chiu K, Ibanez M, Pedraza M, Seo T, Do L, Cho S, Cahiwat J, Tam B, Tambiah JRS, Hood J, Lane NE, Yazici Y (2018) A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthr Cartil 26:18–27. https://doi.org/10.1016/j.joca.2017.08.015CrossRef

25.

Lee CC, Lo Y, Ho LJ, Lai JH, Lien SB, Lin LC, Chen CL, Chen TC, Liu FC, Huang HS (2016) A new application of parallel synthesis strategy for discovery of amide-linked small molecules as potent chondroprotective agents in TNF-alpha-stimulated chondrocytes. PLoS One 11:e0149317. https://doi.org/10.1371/journal.pone.0149317CrossRefPubMedPubMedCentral

26.

Yang Y, Fang S (2017) Small non-coding RNAs-based bone regulation and targeting therapeutic strategies. Mol Cell Endocrinol 456:16–35. https://doi.org/10.1016/j.mce.2016.11.018CrossRefPubMed

27.

Srivastava RAK, Cornicelli JA, Markham B, Bisgaier CL (2018) Gemcabene, a first-in-class hypolipidemic small molecule in clinical development, attenuates osteoarthritis and pain in animal models of arthritis and pain. Front Pharmacol 9:471. https://doi.org/10.3389/fphar.2018.00471CrossRefPubMedPubMedCentral

28.

Sun Y, Roberts A, Mauerhan DR, Cox M, Hanley EN (2018) Biological effects and osteoarthritic disease-modifying activity of small molecule CM-01. J Orthop Res 36:309–317. https://doi.org/10.1002/jor.23616CrossRefPubMed

29.

Ziadlou R, Barbero A, Stoddart MJ, Wirth M, Li Z, Martin I, Wang XL, Qin L, Alini M, Grad S (2019) Regulation of inflammatory response in human osteoarthritic chondrocytes by novel herbal small molecules. Int J Mol Sci 20. https://doi.org/10.3390/ijms20225745

30.

Gao F, Peng C, Zheng C, Zhang S, Wu M (2019) miRNA-101 promotes chondrogenic differentiation in rat bone marrow mesenchymal stem cells. Exp Ther Med 17:175–180PubMed

31.

Lolli A, Colella F, De Bari C, van Osch GJ (2019) Targeting anti-chondrogenic factors for the stimulation of chondrogenesis: a new paradigm in cartilage repair. J Orthop Res 37:12–22CrossRefPubMed

32.

Nixon AJ, Grol MW, Lang HM, Ruan MZC, Stone A, Begum L, Chen Y, Dawson B, Gannon F, Plutizki S, Lee BHL, Guse K (2018) Disease-modifying osteoarthritis treatment with interleukin-1 receptor antagonist gene therapy in small and large animal models. Arthritis Rheumatol 70:1757–1768. https://doi.org/10.1002/art.40668CrossRefPubMed

33.

Roseti L, Desando G, Cavallo C, Petretta M, Grigolo B (2019) Articular cartilage regeneration in osteoarthritis. Cells 8. https://doi.org/10.3390/cells8111305

34.

Kim M-K, Ha C-W, In Y, Cho S-D, Choi E-S, Ha J-K, Lee J-H, Yoo J-D, Bin S-I, Choi C-H (2018) A multicenter, double-blind, phase III clinical trial to evaluate the efficacy and safety of a cell and gene therapy in knee osteoarthritis patients. Human Gene Ther Clin Dev 29:48–59CrossRef

35.

Evans CH, Ghivizzani SC, Robbins PD (2018) Gene delivery to joints by intra-articular injection. Hum Gene Ther 29:2–14CrossRefPubMedPubMedCentral

36.

Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, Miller C, Regalado SG, Loffredo FS, Pancoast JR, Hirshman MF, Lebowitz J, Shadrach JL, Cerletti M, Kim MJ, Serwold T, Goodyear LJ, Rosner B, Lee RT, Wagers AJ (2014) Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344:649–652. https://doi.org/10.1126/science.1251152CrossRefPubMedPubMedCentral

37.

Li L, Wei X, Wang D, Lv Z, Geng X, Li P, Lu J, Wang K, Wang X, Sun J, Cao X, Wei L (2020) Positive effects of a young systemic environment and high growth differentiation factor 11 levels on chondrocyte proliferation and cartilage matrix synthesis in old mice. Arthritis Rheumatol 72:1123–1133. https://doi.org/10.1002/art.41230CrossRefPubMed

38.

Roseti L, Grigolo B (2017) Host environment: scaffolds and signaling (tissue engineering) articular cartilage regeneration: cells, scaffolds, and growth factors. In: Bio-orthopaedics. Springer. pp. 87–103

39.

Van den Berg W (1999) The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis. Z Rheumatol 58:136–141CrossRefPubMed

40.

Sasaki T, Akagi R, Akatsu Y, Fukawa T, Hoshi H, Yamamoto Y, Enomoto T, Sato Y, Nakagawa R, Takahashi K (2017) The effect of systemic administration of G-CSF on a full-thickness cartilage defect in a rabbit model MSC proliferation as presumed mechanism: G-CSF for cartilage repair. Bone Joint Res 6:123–131CrossRefPubMedPubMedCentral

41.

Mazzocca AD, Lindsay A (2018) Biologics in orthopaedic surgery. Elsevier Health Sciences

42.

Sherman BJ, Chahla J, Glowney J, Frank RM (2019) The role of orthobiologics in the management of osteoarthritis and focal cartilage defects. Orthopedics 42:66–73CrossRefPubMed

43.

Cole BJ, Frank RM (2019) OrthoBiologics in sports medicine: real-time applications are here, and future developments are promising! Clin Sports Med 38:xiii–xiv. https://doi.org/10.1016/j.csm.2018.09.003CrossRefPubMed

44.

Andia I, Maffulli N (2013) Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol 9:721–730CrossRefPubMed

45.

Garbin LC, Olver CS (2020) Platelet-rich products and their application to osteoarthritis. J Equine Vet Sci 86:102820. https://doi.org/10.1016/j.jevs.2019.102820CrossRefPubMed

46.

Lana JF, Macedo A, Ingrao ILG, Huber SC, Santos GS, Santana MHA (2019) Leukocyte-rich PRP for knee osteoarthritis: current concepts. J Clin Orthop Trauma 10:S179–s182. https://doi.org/10.1016/j.jcot.2019.01.011CrossRefPubMedPubMedCentral

47.

Yan R, Gu Y, Ran J, Hu Y, Zheng Z, Zeng M, Heng BC, Chen X, Yin Z, Chen W, Shen W, Ouyang H (2017) Intratendon delivery of leukocyte-poor platelet-rich plasma improves healing compared with leukocyte-rich platelet-rich plasma in a rabbit Achilles tendinopathy model. Am J Sports Med 45:1909–1920. https://doi.org/10.1177/0363546517694357CrossRefPubMed

48.

Lana JF, Huber SC, Purita J, Tambeli CH, Santos GS, Paulus C, Annichino-Bizzacchi JM (2019) Leukocyte-rich PRP versus leukocyte-poor PRP - the role of monocyte/macrophage function in the healing cascade. J Clin Orthop Trauma 10:S7–s12. https://doi.org/10.1016/j.jcot.2019.05.008CrossRefPubMedPubMedCentral

49.

Hohmann E, Tetsworth K, Glatt V (2020) Is platelet-rich plasma effective for the treatment of knee osteoarthritis? A systematic review and meta-analysis of level 1 and 2 randomized controlled trials. Eur J Orthop Surg Traumatol. https://doi.org/10.1007/s00590-020-02623-4

50.

Zhao Z, Ma JX, Ma XL (2020) Different intra-articular injections as therapy for hip osteoarthritis: a systematic review and network meta-analysis. Arthroscopy. https://doi.org/10.1016/j.arthro.2019.09.043

51.

Liu F, Xu H, Huang H (2019) A novel kartogenin-platelet-rich plasma gel enhances chondrogenesis of bone marrow mesenchymal stem cells in vitro and promotes wounded meniscus healing in vivo. Stem Cell Res Ther 10:201. https://doi.org/10.1186/s13287-019-1314-xCrossRefPubMedPubMedCentral

52.

Elder S, Thomason J (2014) Effect of platelet-rich plasma on chondrogenic differentiation in three-dimensional culture. Open Orthop J 8:78–84. https://doi.org/10.2174/1874325001408010078CrossRefPubMedPubMedCentral

53.

Yoshida R, Murray MM (2013) Peripheral blood mononuclear cells enhance the anabolic effects of platelet-rich plasma on anterior cruciate ligament fibroblasts. J Orthop Res 31:29–34CrossRefPubMed

54.

Assirelli E, Filardo G, Mariani E, Kon E, Roffi A, Vaccaro F, Marcacci M, Facchini A, Pulsatelli L (2015) Effect of two different preparations of platelet-rich plasma on synoviocytes. Knee Surg Sports Traumatol Arthrosc 23:2690–2703. https://doi.org/10.1007/s00167-014-3113-3CrossRefPubMed

55.

Chahla J, Mandelbaum BR (2018) Biological treatment for osteoarthritis of the knee: moving from bench to bedside-current practical concepts. Arthroscopy 34:1719–1729. https://doi.org/10.1016/j.arthro.2018.01.048CrossRefPubMed

56.

Chahla J, Mannava S, Cinque ME, Geeslin AG, Codina D, LaPrade RF (2017) Bone marrow aspirate concentrate harvesting and processing technique. Arthrosc Tech 6:e441–e445. https://doi.org/10.1016/j.eats.2016.10.024CrossRefPubMedPubMedCentral

57.

Chahla J, Dean CS, Moatshe G, Pascual-Garrido C, Serra Cruz R, LaPrade RF (2016) Concentrated bone marrow aspirate for the treatment of chondral injuries and osteoarthritis of the knee: a systematic review of outcomes. Orthop J Sports Med 4:2325967115625481. https://doi.org/10.1177/2325967115625481CrossRefPubMedPubMedCentral

58.

Ziegler CG, Van Sloun R, Gonzalez S, Whitney KE, DePhillipo NN, Kennedy MI, Dornan GJ, Evans TA, Huard J, LaPrade RF (2019) Characterization of growth factors, cytokines, and chemokines in bone marrow concentrate and platelet-rich plasma: a prospective analysis. Am J Sports Med 47:2174–2187. https://doi.org/10.1177/0363546519832003CrossRefPubMed

59.

Doyle EC, Wragg NM, Wilson SL (2020) Intraarticular injection of bone marrow-derived mesenchymal stem cells enhances regeneration in knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. https://doi.org/10.1007/s00167-020-05859-z

60.

Wilke MM, Nydam DV, Nixon AJ (2007) Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 25:913–925. https://doi.org/10.1002/jor.20382CrossRefPubMed

61.

Vangsness CT Jr, Farr J 2nd, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M (2014) Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am 96:90–98. https://doi.org/10.2106/jbjs.M.00058CrossRefPubMed

62.

Centeno CJ, Al-Sayegh H, Bashir J, Goodyear S, Freeman MD (2015) A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis. BMC Musculoskelet Disord 16:258. https://doi.org/10.1186/s12891-015-0714-zCrossRefPubMedPubMedCentral

63.

Rodriguez-Fontan F, Piuzzi NS, Kraeutler MJ, Pascual-Garrido C (2018) Early clinical outcomes of intra-articular injections of bone marrow aspirate concentrate for the treatment of early osteoarthritis of the hip and knee: a cohort study. PM & R 10:1353–1359. https://doi.org/10.1016/j.pmrj.2018.05.016CrossRef

64.

Anz AW, Hubbard R, Rendos NK, Everts PA, Andrews JR, Hackel JG (2020) Bone marrow aspirate concentrate is equivalent to platelet-rich plasma for the treatment of knee osteoarthritis at 1 year: a prospective, randomized trial. Orthop J Sports Med 8:2325967119900958. https://doi.org/10.1177/2325967119900958CrossRefPubMedPubMedCentral

65.

Hauser RA, Orlofsky A (2013) Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: a case series. Clin Med Insights Arthritis Musculoskelet Disord 6:65–72. https://doi.org/10.4137/cmamd.S10951CrossRefPubMedPubMedCentral

66.

Kim JD, Lee GW, Jung GH, Kim CK, Kim T, Park JH, Cha SS, You YB (2014) Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. Eur J Orthop Surg Traumatol 24:1505–1511. https://doi.org/10.1007/s00590-013-1393-9CrossRefPubMed

67.

Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O'Connor MI (2017) A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med 45:82–90. https://doi.org/10.1177/0363546516662455CrossRefPubMed

68.

Garza JR, Campbell RE, Tjoumakaris FP, Freedman KB, Miller LS, Santa Maria D, Tucker BS (2020) Clinical efficacy of intra-articular mesenchymal stromal cells for the treatment of knee osteoarthritis: a double-blinded prospective randomized controlled clinical trial. Am J Sports Med 48:588–598. https://doi.org/10.1177/0363546519899923CrossRefPubMed

69.

Bora P, Majumdar AS (2017) Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther 8:145. https://doi.org/10.1186/s13287-017-0598-yCrossRefPubMedPubMedCentral

70.

Southworth TM, Naveen NB, Nwachukwu BU, Cole BJ, Frank RM (2019) Orthobiologics for focal articular cartilage defects. Clin Sports Med 38:109–122. https://doi.org/10.1016/j.csm.2018.09.001CrossRefPubMed

71.

Pers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensebe L, Casteilla L, Fleury S, Bourin P, Noel D, Canovas F, Cyteval C, Lisignoli G, Schrauth J, Haddad D, Domergue S, Noeth U, Jorgensen C (2016) Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Transl Med 5:847–856. https://doi.org/10.5966/sctm.2015-0245CrossRefPubMedPubMedCentral

72.

Yokota N, Hattori M, Ohtsuru T, Otsuji M, Lyman S, Shimomura K, Nakamura N (2019) Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am J Sports Med 47:2577–2583. https://doi.org/10.1177/0363546519864359CrossRefPubMed

73.

Arshi A, Petrigliano FA, Williams RJ, Jones KJ (2020) Stem cell treatment for knee articular cartilage defects and osteoarthritis. Curr Rev Musculoskelet Med 13:20–27. https://doi.org/10.1007/s12178-020-09598-zCrossRefPubMedPubMedCentral

74.

Jorgensen C (2018) Mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: the ADIPOA experience. Orthop Proc 100-B:103–103. https://doi.org/10.1302/1358-992x.2018.16.103CrossRef

75.

Hong Z, Chen J, Zhang S, Zhao C, Bi M, Chen X, Bi Q (2019) Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop 43:1123–1134. https://doi.org/10.1007/s00264-018-4099-0CrossRefPubMed

76.

Jo CH, Chai JW, Jeong EC, Oh S, Kim PS, Yoon JY, Yoon KS (2018) Intratendinous injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of rotator cuff disease: a first-in-human trial. Stem Cells (Dayton, Ohio) 36:1441–1450. https://doi.org/10.1002/stem.2855CrossRef

77.

Schiavone Panni A, Vasso M, Braile A, Toro G, De Cicco A, Viggiano D, Lepore F (2019) Preliminary results of autologous adipose-derived stem cells in early knee osteoarthritis: identification of a subpopulation with greater response. Int Orthop 43:7–13. https://doi.org/10.1007/s00264-018-4182-6CrossRefPubMed

78.

Hurley ET, Yasui Y, Gianakos AL, Seow D, Shimozono Y, Kerkhoffs G, Kennedy JG (2018) Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis. Knee Surg Sports Traumatol Arthrosc 26:3499–3507. https://doi.org/10.1007/s00167-018-4955-xCrossRefPubMed

79.

Cosenza S, Ruiz M, Toupet K, Jorgensen C, Noël D (2017) Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep 7:16214. https://doi.org/10.1038/s41598-017-15376-8CrossRefPubMedPubMedCentral

80.

Mianehsaz E, Mirzaei HR, Mahjoubin-Tehran M, Rezaee A, Sahebnasagh R, Pourhanifeh MH, Mirzaei H, Hamblin MR (2019) Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? Stem Cell Res Ther 10:340. https://doi.org/10.1186/s13287-019-1445-0CrossRefPubMedPubMedCentral

81.

D'Arrigo D, Roffi A, Cucchiarini M, Moretti M, Candrian C, Filardo G (2019) Secretome and extracellular vesicles as new biological therapies for knee osteoarthritis: a systematic review. J Clin Med 8. https://doi.org/10.3390/jcm8111867

82.

Fonsi M, El Amrani A-I, Gervais F, Vincent P (2020) Intra-articular hyaluronic acid and chondroitin sulfate: pharmacokinetic investigation in osteoarthritic rat models. Curr Ther Res 92:100573. https://doi.org/10.1016/j.curtheres.2019.100573CrossRefPubMed

83.

Watanabe H (2004) Cartilage proteoglycan aggregate: structure and function. Clin Calcium 14:9–14 CliCa040710291034PubMed

84.

Armstrong S, Read R, Ghosh P (1994) The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol 21:680–688PubMed

85.

Strauss EJ, Hart JA, Miller MD, Altman RD, Rosen JE (2009) Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions. Am J Sports Med 37:1636–1644CrossRefPubMed

86.

Gupta RC, Lall R, Srivastava A, Sinha A (2019) Hyaluronic acid: molecular mechanisms and therapeutic trajectory. Front Vet Sci 6:192. https://doi.org/10.3389/fvets.2019.00192CrossRefPubMedPubMedCentral

87.

Acuña AJ, Samuel LT, Jeong SH, Emara AK, Kamath AF (2020) Viscosupplementation for hip osteoarthritis: does systematic review of patient-reported outcome measures support use? J Orthop

88.

Miller LE, Fredericson M, Altman RD (2020) Hyaluronic acid injections or oral nonsteroidal anti-inflammatory drugs for knee osteoarthritis: systematic review and meta-analysis of randomized trials. Orthop J Sports Med 8:2325967119897909. https://doi.org/10.1177/2325967119897909CrossRefPubMedPubMedCentral

89.

Berthelot J-M, Sellam J, Maugars Y, Berenbaum F (2019) Cartilage-gut-microbiome axis: a new paradigm for novel therapeutic opportunities in osteoarthritis. RMD Open 5:e001037. https://doi.org/10.1136/rmdopen-2019-001037CrossRefPubMedPubMedCentral

90.

Boer CG, Radjabzadeh D, Medina-Gomez C, Garmaeva S, Schiphof D, Arp P, Koet T, Kurilshikov A, Fu J, Ikram MA, Bierma-Zeinstra S, Uitterlinden AG, Kraaij R, Zhernakova A, van Meurs JBJ (2019) Intestinal microbiome composition and its relation to joint pain and inflammation. Nat Commun 10:4881. https://doi.org/10.1038/s41467-019-12873-4CrossRefPubMedPubMedCentral

91.

Favazzo LJ, Hendesi H, Villani DA, Soniwala S, Dar Q-A, Schott EM, Gill SR, Zuscik MJ (2020) The gut microbiome-joint connection: implications in osteoarthritis. Curr Opin Rheumatol 32:92CrossRefPubMed

92.

Szychlinska MA, Di Rosa M, Castorina A, Mobasheri A, Musumeci G (2019) A correlation between intestinal microbiota dysbiosis and osteoarthritis. Heliyon 5:e01134CrossRefPubMedPubMedCentral

93.

Lin AC, Seeto BL, Bartoszko JM, Khoury MA, Whetstone H, Ho L, Hsu C, Ali SA, Alman BA (2009) Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15:1421CrossRefPubMed

94.

Ruiz-Heiland G, Horn A, Zerr P, Hofstetter W, Baum W, Stock M, Distler JH, Nimmerjahn F, Schett G, Zwerina J (2012) Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis. Ann Rheum Dis 71:400–407CrossRefPubMed

95.

Beck TC, Reichel CM, Helke KL, Bhadsavle SS, Dix TA (2019) Non-addictive orally-active kappa opioid agonists for the treatment of peripheral pain in rats. Eur J Pharmacol 856:172396CrossRefPubMedPubMedCentral

96.

Evseenko D, Wu L (2017) Kappa opioid receptor signaling protects cartilage tissue against posttraumatic degeneration. Osteoarthr Cartil 25:S441–S442CrossRef

97.

Weber AE, Jalali O, Limfat S, Shkhyan R, Van Der Horst R, Lee S, Lin Y, Li L, Mayer EN, Wang L, Liu NQ, Petrigliano FA, Lieberman JR, Evseenko D (2020) Kappa opioids modulate hedgehog signaling to attenuate osteoarthritis. Arthritis Rheumatol. https://doi.org/10.1002/art.41250

98.

Rigoglou S, Papavassiliou AG (2013) The NF-κB signalling pathway in osteoarthritis. Int J Biochem Cell Biol 45:2580–2584CrossRefPubMed

Titel: Biological strategies for osteoarthritis: from early diagnosis to treatment
verfasst von: Alexander E. Weber
Ioanna K. Bolia
Nicholas A. Trasolini
Publikationsdatum: 19.10.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: International Orthopaedics / Ausgabe 2/2021
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-020-04838-w

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

25.04.2024 | Hypertonie | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Biological strategies for osteoarthritis: from early diagnosis to treatment

Abstract

Purpose

Methods

Results

Conclusions

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Effects of umbilical cord mesenchymal stem cells loaded with graphene oxide granular lubrication on cytokine levels in animal models of knee osteoarthritis

Intraosseous injections of platelet rich plasma for knee bone marrow lesions treatment: one year follow-up

Subchondral bone or intra-articular injection of bone marrow concentrate mesenchymal stem cells in bilateral knee osteoarthritis: what better postpone knee arthroplasty at fifteen years? A randomized study

Ankle joint re-balancing in the management of ankle fracture malunion using fibular lengthening: prospective clinical-radiological results at mid-term follow-up

Clinical-radiological outcomes and complications after total ankle replacement through a lateral transfibular approach: a retrospective evaluation at a mid-term follow-up

Evaluation of cartilage biomechanics and knee joint microenvironment after different cell-based treatments in a sheep model of early osteoarthritis

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie